TWD 33.55
(2.29%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Operating Cash Flow | -67.35 Million | -184.37 Million | 457.89 Million | 173.84 Million | - |
Net Income | -639.81 Million | -889.74 Million | 408.88 Million | -55.86 Million | - |
Depreciation & Amortization | 492.47 Million | 442.72 Million | 395.54 Million | 343.76 Million | - |
Deferred income taxes | - | - | - | - | - |
Stock-based compensation | - | 6.04 Million | - | - | - |
Change in working capital | 22.53 Million | 76.6 Million | -324 Million | -42.25 Million | - |
Other non-cash items | 438.83 Million | 238.01 Million | 103.46 Million | 72.39 Million | - |
Investing Cash Flow | -177.54 Million | -295.68 Million | -413.78 Million | -902.86 Million | - |
Investments in PPE | -166.76 Million | -254.58 Million | -528.01 Million | -1.01 Billion | - |
Acquisitions | - | - | - | - | - |
Investment purchases | -335.19 Million | -90.01 Million | -213 Thousand | -36.08 Million | - |
Sales/Maturities of investments | 324.41 Million | 48.52 Million | 113.81 Million | 151.07 Million | - |
Other Investing Activities | -10.77 Million | - | - | - | 6.68 Million |
Financing Cash Flow | 201.87 Million | 603.54 Million | 116.24 Million | 466.45 Million | - |
Debt repayment | -144.89 Million | -651.81 Million | -260.72 Million | -475.47 Million | - |
Dividends payments | - | -26.69 Million | - | - | -146.92 Million |
Common Stock Repurchased | - | -24.51 Million | - | - | - |
Common Stock Issuance | 360.55 Million | 13.08 Million | 387.61 Million | - | - |
Other Financing Activities | -13.77 Million | 856 Thousand | - | -258 Thousand | 11.89 Million |
Accounts receivables | -173.93 Million | - | - | - | - |
Accounts payables | 29.63 Million | - | - | - | - |
Inventory | 130.36 Million | -26.67 Million | -206.39 Million | -151.43 Million | - |
Other working capital | 66.11 Million | - | - | - | - |
Cash at beginning of period | 500.91 Million | 344.81 Million | 276.5 Million | 609.74 Million | - |
Cash at end of period | 466.06 Million | 500.91 Million | 344.81 Million | 276.5 Million | - |
Capital Expenditure | -166.76 Million | -254.58 Million | -528.01 Million | -1.01 Billion | - |
Effect of forex changes on cash | 8.17 Million | 32.62 Million | -92.05 Million | -70.67 Million | - |
Net cash flow / Change in cash | -34.84 Million | 156.1 Million | 68.3 Million | -333.24 Million | - |
Free Cash Flow | -234.12 Million | -438.95 Million | -70.11 Million | -844.43 Million | - |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -40.6 Million | -293.29 Million | -639.81 Million | 57.83 Million | -349.97 Million | -165.11 Million |
Depreciation & Amortization | 120.42 Million | 122.76 Million | 492.47 Million | 125.74 Million | 125.47 Million | 121.22 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -36.16 Million | 43.95 Million | 22.53 Million | 44.24 Million | 28.9 Million | -141.01 Million |
Other non-cash items | 111.4 Million | 115.07 Million | 438.83 Million | 117.21 Million | 118.43 Million | 146.33 Million |
Investing Cash Flow | 148.09 Million | -241.41 Million | -177.54 Million | -34.93 Million | -49 Million | -56.37 Million |
Investments in PPE | -51.57 Million | -44.54 Million | -166.76 Million | -33.84 Million | -41.21 Million | -54.65 Million |
Acquisitions | - | - | - | - | - | - |
Investment purchases | -6.07 Million | -305.88 Million | -335.19 Million | -110.58 Million | -116.25 Million | -108.1 Million |
Sales/Maturities of investments | 205.73 Million | 109.01 Million | 324.41 Million | 109.5 Million | 108.46 Million | 106.38 Million |
Other Investing Activities | 199.66 Million | - | - | - | - | - |
Financing Cash Flow | -266.8 Million | -123.45 Million | 201.87 Million | 58.39 Million | 187.59 Million | 1.91 Million |
Debt repayment | -263.08 Million | -119.78 Million | -144.89 Million | -298.44 Million | -191.39 Million | -5.21 Million |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | 360.55 Million | 360.55 Million | - | - |
Other Financing Activities | -36.91 Million | - | - | - | - | - |
Accounts receivables | -56.98 Million | - | - | - | - | - |
Accounts payables | -9.53 Million | - | - | - | - | - |
Inventory | 43.7 Million | 54.11 Million | 130.36 Million | 55.65 Million | 90.91 Million | -134.14 Million |
Other working capital | 3.39 Million | - | - | - | - | - |
Cash at beginning of period | 153.79 Million | 466.06 Million | 500.91 Million | 405.04 Million | 278.19 Million | 399.55 Million |
Cash at end of period | 125.82 Million | 153.79 Million | 466.06 Million | 466.06 Million | 405.04 Million | 278.19 Million |
Capital Expenditure | -51.57 Million | -44.54 Million | -166.76 Million | -33.84 Million | -41.21 Million | -54.65 Million |
Effect of forex changes on cash | -826 Thousand | -571 Thousand | 8.17 Million | -3.57 Million | 10.82 Million | 3.73 Million |
Net cash flow / Change in cash | -27.96 Million | -312.27 Million | -34.84 Million | 61.02 Million | 126.85 Million | -121.36 Million |
Free Cash Flow | 39.99 Million | 8.62 Million | -234.12 Million | 7.29 Million | -63.76 Million | -125.3 Million |
LTHM
GES
DOCT
9600
PGNYF
ITT